Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Rating) SVP Richard A. Graham sold 2,322 shares of the company’s stock in a transaction on Wednesday, June 14th. The stock was sold at an average price of $10.69, for a total value of $24,822.18. Following the completion of the sale, the senior vice president now owns 354,390 shares […]
Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Rating) were down 3.1% during trading on Tuesday . The company traded as low as $10.79 and last traded at $10.79. Approximately 267,814 shares changed hands during mid-day trading, a decline of 48% from the average daily volume of 510,793 shares. The stock had previously closed at […]
Martingale Asset Management L P acquired a new position in Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Rating) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 60,742 shares of the biopharmaceutical company’s stock, valued at approximately $682,000. Martingale Asset Management L […]
Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Rating) was down 3.1% on Tuesday . The stock traded as low as $10.79 and last traded at $10.79. Approximately 267,814 shares traded hands during trading, a decline of 48% from the average daily volume of 510,793 shares. The stock had previously closed at $11.14. Wall Street Analyst Weigh […]
Opaleye Management Inc. acquired a new stake in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Rating) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 87,600 shares of the biopharmaceutical company’s stock, valued at approximately $983,000. Opaleye Management […]